Detalhe da pesquisa
1.
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
J Virol
; 97(1): e0172322, 2023 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533954
2.
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season.
Clin Infect Dis
; 71(6): 1447-1453, 2020 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31598646
3.
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
Proc Natl Acad Sci U S A
; 114(47): 12578-12583, 2017 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29109276
4.
Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.
Clin Infect Dis
; 67(3): 327-333, 2018 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29471464
5.
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.
Proc Natl Acad Sci U S A
; 111(44): 15798-803, 2014 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25331901
6.
Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
J Infect Dis
; 214(12): 1947-1951, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27923954
7.
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
Science
; 378(6622): 899-904, 2022 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423275
8.
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.
Sci Transl Med
; 12(525)2020 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915303
9.
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
Cell Rep
; 29(13): 4460-4470.e8, 2019 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31875553
10.
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies.
Nat Commun
; 9(1): 3361, 2018 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30135514
11.
The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4+ T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway.
Vaccine
; 36(25): 3650-3665, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29764680
12.
Genomic Circuitry Underlying Immunological Response to Pediatric Acute Respiratory Infection.
Cell Rep
; 22(2): 411-426, 2018 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29320737
13.
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
J Exp Med
; 215(6): 1571-1588, 2018 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29739835
14.
Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells.
Sci Immunol
; 2(8)2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28620653
15.
Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.
Vaccine
; 34(46): 5483-5487, 2016 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27670073
16.
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season.
Cell Rep
; 12(1): 1-6, 2015 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26119736